Industry Insights

Industry Insights

As we enter a new financial year, how does the UK Budget affect the rare disease community?

By admin

10 April 2024

Industry Insights

Living well today: How do we make it happen for the rare diseases community?

By Rebecca Pender

13 March 2024

Industry Insights

Rare Disease Day 2024: Sheela Upadhyaya previews some of the events taking place across the world

By admin

14 February 2024

Industry Insights

The UK Rare Diseases Framework: Sheela Upadhyaya reflects on recent progress across the UK

By admin

12 February 2024

Industry Insights

UK report calls for more government input to make cell and gene therapies a true health system priority

By admin

9 January 2024

Industry Insights

Together4RD: making ERN-industry collaboration a key pillar of the future in the rare disease research ecosystem

By admin

11 October 2023

Industry Insights

Living well with a rare disease: are we really supporting our community to achieve this?

By admin

25 September 2023

Industry Insights

The ABPI Code Partnership events: a step towards better partnerships?

By admin

12 July 2023

Industry Insights

COVID: Three years on—what has changed?

By admin

3 May 2023

Industry Insights

The new world of gene therapy: five questions answered

By admin

8 March 2023

Industry Insights

Red tape is ruining the potential of partnerships between patient groups and the pharmaceutical industry – it’s time for change

By admin

1 March 2023

Industry Insights

Finding investment for gene therapies

By admin

22 February 2023

Industry Insights

“Developing positive change in how we diagnose, treat and care for patients with a rare disease.” Rhetoric or reality?

By admin

1 February 2023

Industry Insights

Living with Gaucher disease: challenging encounters along the patient journey

By admin

17 February 2022